Wallachbeth capital announces completion of abvc biopharma, inc. (nasdaq: abvc) $4.22 million registered direct offering

Jersey city, n.j. , may 16, 2022 /prnewswire/ -- wallachbeth capital llc, a leading provider of capital markets and institutional execution services, announced the completion of the purchase and sale of 2,000,000 shares of common stock of abvc biopharma, inc. (nasdaq: abvc), and warrants to purchase up to 2,000,000 shares of common stock, at a purchase price of $2.11 per share in a registered direct offering for total gross proceeds of $4.22 million, before deducting underwriting discounts and commissions and other estimated offering expenses.
ABVC Ratings Summary
ABVC Quant Ranking